Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation

International Journal of Cardiology
F M BrunkhorstS D Anker


Exposure to bacterial endotoxin, perhaps due to bowel congestion or ischaemia and altered gut permeability, may result in immune activation that is characteristic for patients with severe heart failure. It is known that blood procalcitonin rises in response to bacterial endotoxin exposure. We measured procalcitonin in a group of 29 patients with acute cardiogenic shock and no sign of infection (all without bacteraemia) and 26 with septic shock. Blood was analysed for procalcitonin, interleukin-6, tumour necrosis factor-alpha (TNF-alpha), c-reactive protein (CRP) and neopterin. Patients were managed conventionally in an intensive care unit with no further experimental procedures. Three cardiogenic (10%) and seven septic shock patients (27%) survived. Most patients with acute heart failure surviving 12 h or more (18 of 20) developed a pyrexia (738.0 degrees C) of unknown origin in the absence of positive cultures, with a rise in procalcitonin (1.4+/-0.8 to 48.0+/-16.2 ng/ml, P<0.001), CRP (76.5+/-16.4 to 154.7+/-22.9 mg/l, P<0.001) and neopterin (20.7+/-3.5 to 41.2+/-6.7 nmol/l, P<0.001). Patients with septic shock had higher initial levels of cytokines, and higher peak levels. Those with heart failure surviving (n=3) and those d...Continue Reading


May 13, 1978·Lancet·C J HillyardS Taylor
Mar 1, 1975·The Journal of Clinical Endocrinology and Metabolism·L J DeftosJ G Parthemore
Jan 1, 1977·Nephron·O L SilvaC F Moore
Apr 1, 1975·The Journal of Clinical Endocrinology and Metabolism·D D Canale, R K Donabedian
Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Sep 21, 1990·Science·R R SchumannR J Ulevitch
Mar 16, 1974·Lancet·G MilhaudM S Moukhtar
Mar 1, 1995·Circulation·K Yamauchi-TakiharaT Kishimoto
Jun 16, 1994·The New England Journal of Medicine·R M Califf, J R Bengtson
Oct 8, 1997·Journal of the American College of Cardiology·S D AnkerA J Coats
Dec 31, 1997·Lancet·M HatherillI A Murdoch
May 30, 1998·QJM : Monthly Journal of the Association of Physicians·S D AnkerA J Coats
Oct 3, 1998·Intensive Care Medicine·F M BrunkhorstZ F Forycki
Jun 8, 1999·Current Opinion in Cardiology·G Torre-AmioneD L Mann
Nov 1, 1934·The Journal of Clinical Investigation·A E Cohn, J M Steele

❮ Previous
Next ❯


Oct 16, 2012·International Journal of Legal Medicine·Marc AugsburgerCristian Palmiere
Jul 26, 2006·Wiener klinische Wochenschrift·Gottfried Heinz
Jul 30, 2009·Internal and Emergency Medicine·Luigi M BiasucciAntonella Stefanelli
Sep 30, 2010·Internal and Emergency Medicine·Claudio PicarielloGian Franco Gensini
Aug 7, 2002·International Journal of Cardiology·Klaus K A Witte, Andrew L Clark
Aug 7, 2002·International Journal of Cardiology·Stefan D Anker, Rakesh Sharma
Jan 15, 2000·International Journal of Cardiology·S Price, T Evans
Dec 12, 2001·Journal of the American College of Cardiology·J A WagnerG Ertl
Mar 26, 2005·Journal of Clinical Pathology·D H WyllieT E A Peto
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Gian Paolo CastelliLaura Sgarbi
Dec 17, 2005·Critical Care : the Official Journal of the Critical Care Forum·Michael MeisnerJoachim Schmidt
Jul 8, 2008·Critical Care : the Official Journal of the Critical Care Forum·Daniel EyraudLaurent Hannoun
Jan 5, 2001·Clinical Chemistry and Laboratory Medicine : CCLM·M MeisnerK Reinhart
Dec 17, 2009·Mediators of Inflammation·Hanssa Summah, Jie-Ming Qu
Mar 8, 2016·International Journal of Cardiology·Pierpaolo PellicoriJohn G F Cleland
Feb 26, 2013·Forensic Science International : Synergy·S Bode-JänischF C Bange
Jul 28, 2009·Heart Failure Clinics·Stephan von HaehlingStefan D Anker
Dec 2, 2015·International Journal of Antimicrobial Agents·Zsolt BeczeJános Fazakas
Apr 26, 2015·The Journal of Infectious Diseases·David N Gilbert
Jun 20, 2007·European Journal of Clinical Investigation·S LütholdB Müller
Nov 20, 2008·Journal of Cardiac Surgery·Cristina PratVicente Ausina
Nov 27, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Chieko Mitaka
Feb 14, 2006·Nutrition·Mariana Andrade de OliveiraValbert Nascimento Cardoso
Sep 13, 2014·Journal of the American College of Cardiology·Benjamin Dicken, John G F Cleland
Aug 11, 2015·Journal of Immunology Research·Ildikó LászlóJános Fazakas
Jul 16, 2015·Biomarkers in Medicine·Goran LoncarHans-Dirk Dungen
Feb 5, 2015·Journal of Cardiothoracic and Vascular Anesthesia·Thijs C D RettigPeter G Noordzij
Aug 11, 2016·Clinical Cardiology·Hoong Sern Lim
Aug 11, 2004·Chest·Aaron Joffe
May 22, 2016·Angiology·Uğur CanpolatNihan Bahadir
Sep 18, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M ParkL C P Azevedo
Feb 12, 2010·The Journal of International Medical Research·C BalciH S Karabekir
Feb 22, 2018·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Linda AïssouChristophe Meune
Oct 5, 2017·Biomarkers in Medicine·Natasa CvetinovicGoran Loncar
Feb 6, 2008·Circulation·Harmony R Reynolds, Judith S Hochman
Oct 30, 2004·Annals of Medicine·Stefan D AnkerSabine Strassburg
May 19, 2007·Shock·Bambos M CharalambousH E Montgomery
Aug 8, 2008·Current Opinion in Supportive and Palliative Care·Mitja LainscakStefan D Anker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.